Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection

ClinicalTrials.gov ID: NCT01435226

Public ClinicalTrials.gov record NCT01435226. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) Compared With GS-5885, GS-9451 With Tegobuvir or RBV in Treatment-Experienced Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection

Study identification

NCT ID
NCT01435226
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gilead Sciences
Industry
Enrollment
170 participants

Conditions and interventions

Interventions

  • GS-5885 Drug
  • GS-9451 Drug
  • Ribavirin Drug
  • placebo to match RBV Drug
  • placebo to match tegobuvir Drug
  • tegobuvir Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2011
Primary completion
Dec 31, 2012
Completion
Jun 30, 2013
Last update posted
Dec 16, 2013

2011 – 2013

United States locations

U.S. sites
37
U.S. states
19
U.S. cities
33
Facility City State ZIP Site status
University of Arizona Tucson Arizona 85724
Advanced Clinical Research Institute, LLC Anaheim California 92801
California Liver Institute Beverly Hills California 90211
SCTI Research Foundation Liver Center Coronado California 92118
University of California, San Diego La Jolla California 92161
Lightsource Medical Los Angeles California 90036
Medical Associates Research Group, Inc. San Diego California 92123
Kaiser Permanente San Diego California 92154
California Pacific Medical Center San Francisco California 94115
San Jose Gastroenterology San Jose California 95128
Whitman Walker Clinic Washington D.C. District of Columbia 20037
Avail Clinical Research, LLC DeLand Florida 32720
University of Miami, Center for Liver Diseases Miami Florida 33136
Infectious Disease Specialists of Atlanta Decatur Georgia 30033
University of Kansas Medical Center Kansas City Kansas 66160
Mercy Medical Center Baltimore Maryland 21202
Johns Hopkins University Lutherville Maryland 21093
Massachusetts General Hospital Boston Massachusetts 02114
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Henry Ford Health System Novi Michigan 48377
Weill Medical College of Cornell Univeristy New York New York 10021
Mount Sinai School of Medicine New York New York 10029
Montefiore Medical Center The Bronx New York 10467
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599
University of Pennsylvania Philadelphia Pennsylvania 19104
University Gastroenterology Providence Rhode Island 02905
Gastro One Germantown Tennessee 38138
Southwest Infectious Disease Clinical Research, Inc Dallas Texas 75204
University of Texas Medical Branch Galveston Texas 77555
Therapeutic Concepts, PA Houston Texas 77004
The University of Texas Health Sciences Center at Houston Houston Texas 77030
Alamo Medical Research, Ltd. San Antonio Texas 78215
University of Utah Salt Lake City Utah 84132
Bon Secours St. Mary's Hospital of Richmond, Inc. Newport News Virginia 23602
Digestive and Liver Disease Specialists Norfolk Virginia 23502
Virginia Mason Medical Center Seattle Washington 98101
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01435226, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 16, 2013 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01435226 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →